Specialty Pharmacy

Funds from social media phenomenon leads to breakthrough discovery in amyotrophic lateral sclerosis (ALS).

Add-on therapy to interferon beta-1a is a potentially groundbreaking oral antibiotic combination.

Neratinib and the combination of veliparib plus carboplatin improves breast cancer outcomes.

Top news from across the health care landscape.

Anti-PD-L1 immunotherapy with an MEK inhibitor may improve treatment of microsatellite-stable metastatic colorectal cancer.

Researchers created an algorithm that can discover how the immune system responds to cancer.

Microscopic silk swimming device may improve treatment for variety of diseases.

Zepatier is already approved in the United States and Canada for treatment of hepatitis C.

Prescribers and patients can no longer blindly rely on simple and straightforward drug delivery in specialty pharmacy.

Ipilimumab combined with local peripheral treatments shows promise in malignant melanoma.

Researchers seek to induce broadly neutralizing antibodies to block numerous HIV variants.

Top news of the day from across the health care landscape.

More than a half-billion people may have diabetes worldwide.

Intestinal microbiota may help predict rheumatoid arthritis symptom severity and frequency.

Stage 2 colon cancer patients administered adjuvant chemotherapy survived significantly longer than patients who did not.

Support groups and social networking help breast cancer patients manage emotions and stress.

United States Preventive Service Task Force screening guidelines for diabetes found to miss more than half of high-risk patients.

Burdock root, or gobo, associated with lower rates of colon cancer and colitis.

Chemotherapy drug may cause the loss of hearing during the treatment of testicular cancer.

Overexpression of Aurora Kinase could potentially inhibit a tumor suppressing gene.

The specialty pharmacist has to balance myriad competing priorities in managing a specialty therapy regimen.

Top articles of the week on Specialty Pharmacy Times.

Top news of the week from across the health care landscape.

Understanding cellular mechanism can improve treatment of chronic inflammatory disease.

Research could lead to improved personalized therapies for acute myeloid leukemia.

Selenocompounds were able to kill up to 80% of cancer cells in mice.

Specialty pharmacies need to maintain services that ensure optimal patient care and outcomes.

Patients treated for high cholesterol showed improved survival in bowel, breast, lung, and prostate cancers.